Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study

Diagn Microbiol Infect Dis. 2011 Mar;69(3):307-13. doi: 10.1016/j.diagmicrobio.2010.10.026.

Abstract

This study assessed the epidemiology and antimicrobial resistance of pathogens associated with bloodstream infections in Canadian hospitals between 2007 and 2009. Tertiary-care medical centers representing 8 of 10 Canadian provinces submitted bloodstream infection pathogens from patients attending hospital clinics, emergency rooms, medical/surgical wards, and intensive care units. Over 8,000 blood culture pathogens were collected. The 10 most common pathogens (representing 80.9% of all isolates) were Escherichia coli (1856 [22.6%]), Staphylococcus aureus (1457 [17.7%] including 1101 methicillin-susceptible Staphylococcus aureus and 356 methicillin-resistant Staphylococcus aureus), coagulase-negative staphylococci (907 [11.0%]), Klebsiella pneumoniae (600 [7.3%]), Streptococcus pneumoniae (470 [5.7%]), Enterococcus faecalis (360 [4.4%]), Pseudomonas aeruginosa (333 [4.0%]), viridans group streptococci (321 [3.9%]), Enterobacter cloacae (193 [2.3%]), and Streptococcus pyogenes (159 [1.9%]). The most active agents against Gram-negative bacilli were carbapenems (e.g., meropenem and ertapenem) and piperacillin-tazobactam, while for Gram-positive cocci, they were vancomycin, linezolid, and daptomycin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Infective Agents / pharmacology
  • Blood / microbiology*
  • Canada / epidemiology
  • Candida / drug effects*
  • Carbapenems / pharmacology
  • Child
  • Child, Preschool
  • Drug Resistance, Bacterial*
  • Drug Resistance, Fungal*
  • Emergency Service, Hospital
  • Gram-Negative Bacteria / drug effects*
  • Gram-Negative Bacteria / isolation & purification
  • Gram-Positive Bacteria / drug effects*
  • Gram-Positive Bacteria / isolation & purification
  • Humans
  • Infant
  • Infant, Newborn
  • Intensive Care Units
  • Microbial Sensitivity Tests
  • Middle Aged
  • Outpatient Clinics, Hospital
  • Patients' Rooms
  • Penicillanic Acid / analogs & derivatives
  • Penicillanic Acid / pharmacology
  • Piperacillin / pharmacology
  • Piperacillin, Tazobactam Drug Combination
  • Polymerase Chain Reaction
  • Prevalence
  • Sepsis / drug therapy
  • Sepsis / epidemiology
  • Sepsis / microbiology*

Substances

  • Anti-Infective Agents
  • Carbapenems
  • Piperacillin, Tazobactam Drug Combination
  • Penicillanic Acid
  • Piperacillin